Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial

被引:15
|
作者
Stellamans, K
Lievens, Y
Lambin, P
Van den Weyngaert, D
Van den Bogaert, W
Scalliet, P
Hutsebaut, L
Haustermans, K
机构
[1] UZ Gasthuisberg, Univ Hosp Leuven, Dept Radiotherapy, B-3000 Louvain, Belgium
[2] AZ Middelheim, Dept Radiotherapy, Antwerp, Belgium
[3] UZ Gasthuisberg, Dept Pharmaceut, Louvain, Belgium
关键词
sucralfate; pelvic irradiation; side effects;
D O I
10.1016/S0167-8140(02)00281-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Study and methods: A double-blind placebo-controlled study randomized 108 patients to investigate the effect of sucralfate on gastrointestinal side effects of pelvic radiation. Results: Overall, pelvic radiation with the administered doses and fields and performed according to nowadays technical standards, was well tolerated. Comparison of the mean scores and the peak reactions for radiotherapy discomfort, diarrhoea and number of stools per day in the 80 evaluable patients showed no statistically significant difference between sucralfate and placebo. Conclusion: Based on these results, the use of sucralfate can not be recommended as standard practice. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条
  • [1] Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial
    Lievens, Y
    Haustermans, K
    Van den Weyngaert, D
    Van den Bogaert, W
    Scalliet, P
    Hutsebaut, L
    Fowler, J
    Lambin, P
    RADIOTHERAPY AND ONCOLOGY, 1998, 47 (02) : 149 - 153
  • [2] Sucralfate for radiation mucositis: Results of a double-blind randomized trial
    Meredith, R
    Salter, M
    Kim, R
    Spencer, S
    Weppelmann, B
    Rodu, B
    Smith, J
    Lee, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (02): : 275 - 279
  • [3] Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial
    Martin, T
    Uhder, K
    Kurek, R
    Roeddiger, S
    Schneider, L
    Vogt, HG
    Heyd, R
    Zamboglou, N
    RADIOTHERAPY AND ONCOLOGY, 2002, 65 (01) : 17 - 22
  • [4] A randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation
    Demers, Mimi
    Dagnault, Anne
    Desjardins, Josee
    CLINICAL NUTRITION, 2014, 33 (05) : 761 - 767
  • [5] Olsalazine is contraindicated during pelvic radiation therapy: Results of a double-blind, randomized clinical trial
    Martenson, JA
    Hyland, G
    Moertel, CG
    Mailliard, JA
    OFallon, JR
    Collins, RT
    Morton, RF
    Tewfik, HH
    Moore, RL
    Frank, AR
    Urias, RE
    Deming, RL
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (02): : 299 - 303
  • [6] SUCRALFATE THERAPY IN PATIENTS WITH SYMPTOMS OF ALKALINE REFLUX GASTRITIS - A RANDOMIZED DOUBLE-BLIND TRIAL
    BUCK, K
    TEDESCO, F
    WEINSTEIN, W
    HILL, T
    IPPOLITI, A
    REEDY, T
    ELASHOFF, J
    GASTROENTEROLOGY, 1984, 86 (05) : 1037 - 1037
  • [7] Prednisolone does not reduce withdrawal headache -: A randomized, double-blind study
    Boe, Magne G.
    Mygland, Ase
    Salvesen, Rolf
    NEUROLOGY, 2007, 69 (01) : 26 - 31
  • [8] SUCRALFATE IN DUODENAL-ULCER DISEASE - A DOUBLE-BLIND TRIAL
    SHENNAK, MM
    ALSHEIKH, TM
    ABURAJAB, MT
    ANNALS OF SAUDI MEDICINE, 1988, 8 (06) : 443 - 447
  • [9] Topical Tranexamic Acid Does Not Reduce Hematoma in Reduction Mammaplasty: A Double-Blind Randomized Controlled Trial
    Brown, Stav
    Rohrich, Rod J.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2025, 155 (03) : 643e - 644e
  • [10] Topical Tranexamic Acid Does Not Reduce Hematoma in Reduction Mammaplasty: A Double-Blind Randomized Controlled Trial
    Yao, Amy
    Wang, Fei
    Benacquista, Teresa
    Draper, Lawrence B.
    Garfein, Evan S.
    Monaco, Casian
    Tepper, Oren M.
    Weichman, Katie E.
    Ricci, Joseph A.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 154 (01) : 30 - 37